Back HIV/AIDS

HIV / AIDS

ViiV Survey Reveals Gaps in Knowledge About HIV and its Treatment

A majority of HIV positive people in the U.S. who have not started antiretroviral therapy (ART) are unaware that treatment can prevent HIV transmission to their partners, and about one-third believe antiretroviral side effects are worse than HIV itself, according to a survey conducted by Harris Interactive on behalf of ViiV Healthcare.

alt

Studies Reveal HIV and HCV Epidemics Among Injection Drug Users in the Middle East and North Africa

At least one-third of countries in the Middle East and North Africa that historically have had low rates of HIV infection now have emerging epidemics largely attributable to injection drug use, according to a systematic review published in the June 17 edition of the open access journal PLoS Medicine. Rates of hepatitis C virus (HCV) infection also appear to be high and rising.

alt

Clinical Trial of Once-Daily Raltegravir Now Underway

Merck announced this week that treatment-naive participants are now being enrolled in the Phase 3 ONCEMRK trial, which is evaluating the efficacy and safety of a ne formulation of the HIV integrase inhibitor raltegravir (Isentress) taken once rather than twice daily.

alt

Janssen and ViiV to Develop NRTI-free Single-tablet Regimen

Janssen R&D and ViiV Healthcare announced last week that they will collaborate on the development of a dual single-tablet regimen containing the non-nucleoside reverse transcriptase inhibitor (NNRTI) rilpivirine and the new integrase inhibitor dolutegravir, to be used as maintenance therapy for people who achieve viral suppression using a traditional regimen.

alt

People with HIV Are at Higher Risk for Cancers Linked to Smoking, Viruses

People with HIV appeared to have a higher overall rate of cancer in a large Danish study, but the difference was only significant for malignancies caused by smoking or other viruses, including lung cancer, anal cancer, and liver cancer. A related U.S. study found the rate of prostate cancer was actually lower among HIV positive men.

alt

Atlanta Principles Call for Stepped Up HIV Prevention, Focus on Vulnerable Groups

ACT UP, the Treatment Action Group (TAG), and local advocates this week launched the Atlanta Principles, calling on the Centers for Disease Control and Prevention (CDC) to increase HIV prevention efforts -- including antiretroviral treatment-as-prevention and pre- and post-exposure prophylaxis -- to lower HIV incidence rates that have remained stable overall for several years and actually risen for heavily affected groups such as young black gay men and transgender women.

alt

June 5 is National HIV/AIDS Long-Term Survivors Awareness Day

The first National HIV/AIDS Long-Term Survivor Awareness Day (NHALTSAD) will take place this week on June 5. The day is one that has historical significance in San Francisco, but also globally, because it was the same day in 1981 that the U.S. Centers for Disease Control (CDC) reported the first cases of a new and devastating disease we now know as AIDS.

alt